Rapid microbiology testing market 2023-2027: Growth opportunities led by Abbott Laboratories and Becton Dickinson and Co. - Technavio

NEW YORK, Dec. 12, 2022 /PRNewswire/ -- The rapid microbiology testing market size is estimated to increase by USD 2,487.91 million from 2022 to 2027, with an accelerated CAGR of 9.31%, according to the recent market study by Technavio. This report also offers a 5-year historical (2017-2021) data projection of market size, segmentation, and region.

Discover some insights on market size before buying the full report. Request a sample
report.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak. The bargaining power of buyers and suppliers and the threat of new entrants, rivalry, and substitutes have also been analyzed and rated between LOW-MODERATE to provide a holistic view of market favorability.

Find Technavio's exclusive analysis of price sensitivity, adoption lifecycle, customer purchase basket, adoption rates, and purchase criteria

• One of the core components of the customer landscape is price sensitivity, an analysis of which will help companies refine marketing strategies to gain a competitive advantage. 
• Another key aspect is price sensitivity drivers (purchases are undifferentiated, purchase is a key cost to buyers, and quality is not important), which range between LOW and HIGH.
• Furthermore, market adoption rates for all regions have been covered.

The rapid microbiology testing market report also offers information on the criticality of inputs, R&D, CAPEX, technology, and products of 15 vendors listed below –

• Becton Dickinson and Co.
• bioMerieux SA
• Biosensia Ltd.
• Bruker Corp.
• Charles River Laboratories
• Colifast AS
• Danaher Corp.
• Don Whitley Scientific Ltd.
• Euroclone SpA
• Gradientech AB
• Merck KGaA
• Neogen Corp.
• Quidel Corp.
• Rapid Micro Biosystems Inc.
• rqMicro AG.

Download a sample report 

Chart and data table on 5-year historic (2017-2021) market size, comparative analysis of segments, and Y-O-Y growth of rapid microbiology testing market

• The market is segmented by method (growth-based, nucleic-acid-based, viability-based, and others) and end-user (hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, and others).
• Based on method, the growth-based segment will account for the largest share of the market's growth during the forecast period.
• The growth of this segment is primarily attributed to an increase in the early detection of infectious diseases.
• Growth-based rapid microbiological testing relies on the detection of biochemical or physiological growth indicators. It can provide a quantitative cell count, an estimation of viable cell concentration, information about the presence of specific microorganisms, and microbial identification.

To procure the data - Buy report!

Increasing incidence of infectious diseases and cancer is notably driving the rapid microbiology testing market growth

The incidence of infectious diseases such as tuberculosis, HIV, pneumonia, and malaria has increased. Hence, the number of awareness programs related to these diseases has also increased to encourage preventive healthcare and early diagnosis. With the rise in the number of cases of such diseases, the demand for rapid microbiology techniques has increased. These techniques enable fast and accurate microbial screening, identification, and testing against pathogens, which is expected to drive the growth of the market during the forecast period.

Chart and data table on historical market size (2017-2021), historic industry size, and analysis of vendors and countries

The market is segmented by region (North America, Europe, Asia, and the Rest of World). An analysis of key leading countries has been included.

• North America is estimated to contribute 41% to the growth of the global market during the forecast period. Growth will be driven by the growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several vendors offering a wide range of products. The US is the key market for the rapid microbiology testing market in the region.
• In 2021, business and industrial activities resumed owing to the lifting of lockdown restrictions and vaccination drives for COVID-19. This resulted in the resumption of rapid microbiology testing in clinics and hospitals, which increased its demand. Moreover, factors such as the rise in the number of diseases such as bacterial infection will fuel the growth of the regional market during the forecast period.

For insights on the market dynamics and segmentations, view a PDF sample!

Related reports -

Food pathogen testing market by application and geography - Forecast and analysis 2022-2026 – size is estimated to increase by USD 3 billion from 2021 to 2026, with an accelerated CAGR of 6.39%, according to the recent market study by Technavio. Furthermore, this report extensively covers market segmentation by application (meat and poultry, dairy, processed food, fruits and vegetables, and cereals and grains) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). To get more exclusive research insights: View summary of the report 

Toxicology testing market by technology, end-user, and geography - Forecast and analysis 2023-2027 – size is estimated to increase by USD 27.5 billion from 2022 to 2027, with an accelerated CAGR of 15.09%, according to the recent market study by Technavio. The rise in toxicology testing in the food industry is one of the key factors driving the market growth. To get more exclusive research insights: View summary of the report 

Register today and gain instant access to 17,000+ market research reports. 
Technavio's SUBSCRIPTION platform

What are the key data covered in this rapid microbiology testing market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the rapid microbiology testing market between 2023 and 2027
• Precise estimation of the size of the rapid microbiology testing market and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the rapid microbiology testing market across North America, Asia, Europe, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of rapid microbiology testing market vendors

Browse for Technavio's health care market reports

Table of contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Method
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global rapid microbiology testing market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on Global rapid microbiology testing market 2017 - 2021 ($ million)

• 4.2 Method Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Method Segment 2017 - 2021 ($ million)

• 4.3 End-User Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – End-User Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Method

• 6.1 Market segments 
• Exhibit 30: Chart on Method - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Method - Market share 2022-2027 (%)

• 6.2 Comparison by Method 
• Exhibit 32: Chart on Comparison by Method
• Exhibit 33: Data Table on Comparison by Method

• 6.3 Growth-based - Market size and forecast 2022-2027
• Exhibit 34: Chart on Growth-based - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Growth-based - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Growth-based - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Growth-based - Year-over-year growth 2022-2027 (%)

• 6.4 Nucleic-acid based - Market size and forecast 2022-2027
• Exhibit 38: Chart on Nucleic-acid based - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Nucleic-acid based - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Nucleic-acid based - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Nucleic-acid based - Year-over-year growth 2022-2027 (%)

• 6.5 Viability-based - Market size and forecast 2022-2027
• Exhibit 42: Chart on Viability-based - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Viability-based - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Viability-based - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Viability-based - Year-over-year growth 2022-2027 (%)

• 6.6 Others - Market size and forecast 2022-2027
• Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 6.7 Market opportunity by Method 
• Exhibit 50: Market opportunity by Method ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments 
• Exhibit 51: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 52: Data Table on End-user - Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 53: Chart on Comparison by End-user
• Exhibit 54: Data Table on Comparison by End-user

• 7.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 
• Exhibit 55: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)

• 7.4 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 
• Exhibit 59: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)

• 7.5 Others - Market size and forecast 2022-2027
• Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by End-user 
• Exhibit 67: Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 69: Chart on Market share by geography 2022-2027 (%)
• Exhibit 70: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 71: Chart on Geographic comparison
• Exhibit 72: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Asia - Market size and forecast 2022-2027
• Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.5 Europe - Market size and forecast 2022-2027
• Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 China - Market size and forecast 2022-2027
• Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape 
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 112: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 114: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 115: Matrix on vendor position and classification

• 12.3 Abbott Laboratories 
• Exhibit 116: Abbott Laboratories - Overview
• Exhibit 117: Abbott Laboratories - Business segments
• Exhibit 118: Abbott Laboratories - Key news
• Exhibit 119: Abbott Laboratories - Key offerings
• Exhibit 120: Abbott Laboratories - Segment focus

• 12.4 Becton Dickinson and Co. 
• Exhibit 121: Becton Dickinson and Co. - Overview
• Exhibit 122: Becton Dickinson and Co. - Business segments
• Exhibit 123: Becton Dickinson and Co. - Key news
• Exhibit 124: Becton Dickinson and Co. - Key offerings
• Exhibit 125: Becton Dickinson and Co. - Segment focus

• 12.5 bioMerieux SA 
• Exhibit 126: bioMerieux SA - Overview
• Exhibit 127: bioMerieux SA - Product / Service
• Exhibit 128: bioMerieux SA - Key offerings

• 12.6 Bruker Corp. 
• Exhibit 129: Bruker Corp. - Overview
• Exhibit 130: Bruker Corp. - Business segments
• Exhibit 131: Bruker Corp. - Key news
• Exhibit 132: Bruker Corp. - Key offerings
• Exhibit 133: Bruker Corp. - Segment focus

• 12.7 Charles River Laboratories 
• Exhibit 134: Charles River Laboratories - Overview
• Exhibit 135: Charles River Laboratories - Business segments
• Exhibit 136: Charles River Laboratories - Key news
• Exhibit 137: Charles River Laboratories - Key offerings
• Exhibit 138: Charles River Laboratories - Segment focus

• 12.8 Danaher Corp. 
• Exhibit 139: Danaher Corp. - Overview
• Exhibit 140: Danaher Corp. - Business segments
• Exhibit 141: Danaher Corp. - Key news
• Exhibit 142: Danaher Corp. - Key offerings
• Exhibit 143: Danaher Corp. - Segment focus

• 12.9 Don Whitley Scientific Ltd. 
• Exhibit 144: Don Whitley Scientific Ltd. - Overview
• Exhibit 145: Don Whitley Scientific Ltd. - Product / Service
• Exhibit 146: Don Whitley Scientific Ltd. - Key offerings

• 12.10 Gradientech AB 
• Exhibit 147: Gradientech AB - Overview
• Exhibit 148: Gradientech AB - Product / Service
• Exhibit 149: Gradientech AB - Key offerings

• 12.11 Merck KGaA 
• Exhibit 150: Merck KGaA - Overview
• Exhibit 151: Merck KGaA - Business segments
• Exhibit 152: Merck KGaA - Key news
• Exhibit 153: Merck KGaA - Key offerings
• Exhibit 154: Merck KGaA - Segment focus

• 12.12 Neogen Corp. 
• Exhibit 155: Neogen Corp. - Overview
• Exhibit 156: Neogen Corp. - Business segments
• Exhibit 157: Neogen Corp. - Key news
• Exhibit 158: Neogen Corp. - Key offerings
• Exhibit 159: Neogen Corp. - Segment focus

• 12.13 Quidel Corp. 
• Exhibit 160: Quidel Corp. - Overview
• Exhibit 161: Quidel Corp. - Product / Service
• Exhibit 162: Quidel Corp. - Key offerings

• 12.14 Rapid Micro Biosystems Inc. 
• Exhibit 163: Rapid Micro Biosystems Inc. - Overview
• Exhibit 164: Rapid Micro Biosystems Inc. - Product / Service
• Exhibit 165: Rapid Micro Biosystems Inc. - Key offerings

• 12.15 rqMicro AG 
• Exhibit 166: rqMicro AG - Overview
• Exhibit 167: rqMicro AG - Product / Service
• Exhibit 168: rqMicro AG - Key offerings

• 12.16 Sartorius AG 
• Exhibit 169: Sartorius AG - Overview
• Exhibit 170: Sartorius AG - Business segments
• Exhibit 171: Sartorius AG - Key news
• Exhibit 172: Sartorius AG - Key offerings
• Exhibit 173: Sartorius AG - Segment focus

• 12.17 Thermo Fisher Scientific Inc. 
• Exhibit 174: Thermo Fisher Scientific Inc. - Overview
• Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 176: Thermo Fisher Scientific Inc. - Key news
• Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 179: Inclusions checklist
• Exhibit 180: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 181: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 182: Research methodology
• Exhibit 183: Validation techniques employed for market sizing
• Exhibit 184: Information sources

• 13.5 List of abbreviations 
• Exhibit 185: List of abbreviations

About us 

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio